PharmaFluidics raises 2.7 million euro to commercialize novel micro-chip device for Biomarker, Diagnostics and Drug development applications

VUB spin-off PharmaFluidics NV, a game-changing innovator in the field of analytical
chromatography, announced that it has raised 2.7 million euro of additional funding.

More info and several articles in the press can be found here.